Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy

Completed · Phase 3 · Has a placebo group

Conditions studied: Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Gabapentin may prevent or reduce delayed nausea and vomiting caused by chemotherapy. It is not yet known whether gabapentin is more effective than a placebo in preventing nausea and vomiting. PURPOSE: This randomized phase III trial is studying the side effects of gabapentin and to see how well it works compared with a placebo in preventing nausea and vomiting in patients receiving chemotherapy.

Key facts

Study ID
NCT00880191
Run by
Alliance for Clinical Trials in Oncology
People needed
430
Starts
2009-04-01
Expected to finish
2015-05-01
Last updated by the study team
2016-07-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.